Valley Wealth Managers Inc. Sells 8,819 Shares of Cencora, Inc. $COR

Valley Wealth Managers Inc. cut its position in Cencora, Inc. (NYSE:COR) by 10.3% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 77,025 shares of the company’s stock after selling 8,819 shares during the quarter. Cencora comprises 1.6% of Valley Wealth Managers Inc.’s portfolio, making the stock its 26th biggest holding. Valley Wealth Managers Inc.’s holdings in Cencora were worth $24,197,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. JFS Wealth Advisors LLC increased its stake in Cencora by 30.2% in the fourth quarter. JFS Wealth Advisors LLC now owns 125 shares of the company’s stock valued at $42,000 after acquiring an additional 29 shares during the last quarter. Apollon Wealth Management LLC lifted its stake in Cencora by 0.5% during the fourth quarter. Apollon Wealth Management LLC now owns 6,527 shares of the company’s stock worth $2,205,000 after purchasing an additional 30 shares during the last quarter. Accent Capital Management LLC lifted its stake in Cencora by 36.1% during the fourth quarter. Accent Capital Management LLC now owns 113 shares of the company’s stock worth $38,000 after purchasing an additional 30 shares during the last quarter. MCF Advisors LLC boosted its holdings in shares of Cencora by 11.0% in the 4th quarter. MCF Advisors LLC now owns 303 shares of the company’s stock valued at $102,000 after purchasing an additional 30 shares in the last quarter. Finally, CYBER HORNET ETFs LLC boosted its holdings in shares of Cencora by 6.8% in the 4th quarter. CYBER HORNET ETFs LLC now owns 485 shares of the company’s stock valued at $164,000 after purchasing an additional 31 shares in the last quarter. Institutional investors own 97.52% of the company’s stock.

Insider Buying and Selling

In related news, Director Lauren M. Tyler bought 550 shares of the business’s stock in a transaction on Monday, June 22nd. The shares were purchased at an average cost of $270.23 per share, with a total value of $148,626.50. Following the acquisition, the director owned 4,359 shares of the company’s stock, valued at $1,177,932.57. This represents a 14.44% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.38% of the company’s stock.

Wall Street Analyst Weigh In

COR has been the subject of a number of research analyst reports. Weiss Ratings cut Cencora from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 30th. UBS Group raised their price objective on Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. Barclays decreased their target price on Cencora from $425.00 to $350.00 and set an “overweight” rating on the stock in a research report on Wednesday, June 10th. Wells Fargo & Company lowered their target price on Cencora from $429.00 to $331.00 and set an “overweight” rating for the company in a research note on Monday, May 11th. Finally, Morgan Stanley set a $342.00 target price on shares of Cencora in a report on Friday, May 8th. Eleven equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $367.75.

Cencora Trading Down 0.1%

Shares of NYSE COR opened at $307.72 on Friday. The firm has a 50 day moving average price of $279.98 and a two-hundred day moving average price of $317.68. The stock has a market cap of $59.87 billion, a P/E ratio of 23.60, a price-to-earnings-growth ratio of 1.71 and a beta of 0.58. Cencora, Inc. has a 52-week low of $244.82 and a 52-week high of $377.54. The company has a debt-to-equity ratio of 3.40, a quick ratio of 0.59 and a current ratio of 0.95.

Cencora (NYSE:COR) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a return on equity of 135.20% and a net margin of 0.78%.The business had revenue of $78.36 billion for the quarter, compared to analyst estimates of $81.09 billion. During the same quarter last year, the firm posted $4.42 EPS. Cencora’s revenue for the quarter was up 3.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, equities analysts forecast that Cencora, Inc. will post 17.79 EPS for the current year.

Cencora declared that its board has approved a share buyback program on Thursday, May 21st that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the company to purchase up to 3.9% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s board of directors believes its shares are undervalued.

Cencora Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were issued a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 annualized dividend and a yield of 0.8%. Cencora’s payout ratio is presently 18.40%.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.